LACTASE FROM SACCHAROMYCES FRAGILIS
Lactase from Saccharomyces fragilis is a microbial enzyme preparation used in food processing to hydrolyze lactose. It is listed in the FDA Substances Added to Food inventory and recognized in enzyme preparatory contexts.
What It Is
Lactase from Saccharomyces fragilis is a microbial-derived enzyme preparation identified by the CAS number 977090-10-0 and classified primarily by its biochemical function as an enzyme that catalyzes the hydrolysis of lactose, a disaccharide sugar found in milk and dairy products. Lactase broadly refers to enzymes belonging to the family of glycoside hydrolases that break the beta-glycosidic bond in lactose to produce its constituent monosaccharides. In this context, the term lactase is often interchangeable with beta-D-galactosidase, emphasizing its catalytic activity on lactose substrates. The specific identification of this enzyme preparation as coming from the yeast species Saccharomyces fragilis reflects the microbial source used for industrial production and processing applications. The enzyme itself does not impart flavor or nutritional components beyond its catalytic function but serves a biochemical role in modifying carbohydrate content in food matrices. Lactase from Saccharomyces fragilis is listed in inventories that document food substances and enzyme preparations used in food processing. For example, it appears in the United States Food and Drug Administration (FDA) Substances Added to Food inventory, reflecting its recognition as a food substance with a technical function in food processing. This listing does not, by itself, confer or prove specific regulatory approvals for defined food uses under particular codified regulations, but it establishes that the substance has been cataloged in official documentation used by regulators to track food ingredient information. In addition, enzyme preparations like lactase must comply with established food safety and manufacturing practice requirements when used to process foods. At a high level, this enzyme preparation fits within the broader class of food enzymes employed to support processing steps such as lactose breakdown. Food enzymes like lactase are often derived from microbial sources because of their efficiency and consistency in industrial applications. The term enzyme in this context refers to a biologically produced protein catalyst, which, when incorporated into food processing systems, can selectively accelerate chemical reactions without itself being consumed in the process. In commercial food science, microbial enzymes are widely used to improve functional properties of foods, facilitate ingredient transformations, and meet specific dietary or quality attributes.
How It Is Made
Lactase from Saccharomyces fragilis is produced through fermentation processes that leverage the metabolic activity of the yeast Saccharomyces fragilis to synthesize the enzyme. In industrial enzyme manufacturing, a defined production strain of the microorganism is cultivated under controlled conditions in nutrient media designed to promote high yields of the target enzyme. After sufficient enzyme production, the culture is processed to separate the enzyme from the microbial biomass and other fermentation byproducts, typically through filtration, centrifugation, and purification steps that concentrate the enzyme and remove unwanted components. This general approach to enzyme manufacture aligns with standard practices for producing food-grade enzyme preparations, which emphasize control of microbial quality and consistency of enzyme activity. The production strain used to generate lactase is selected for traits such as high enzyme yield, stability, and the absence of harmful metabolic byproducts. Good manufacturing practices (GMP) in enzyme production require that the source organism be nonpathogenic, non-toxigenic, and taxonomically characterized to enable traceability and quality control. Microbial sources, like Saccharomyces species, are often preferred for food enzyme production because of their long history of safe use and well-established fermentation performance. During the production process, the culture conditions – such as temperature, pH, nutrient availability, and aeration – are optimized to stimulate enzyme biosynthesis rather than excessive biomass growth. Once fermentation is completed, the enzyme-rich broth undergoes downstream processing steps to isolate lactase. These may include cell removal, concentration of enzyme protein, and formulation into a stable preparation. Enzyme preparations may also be standardized by measuring Total Organic Solids (T.O.S.) to define the proportion of active enzyme relative to carriers and other excipients. Purity considerations often involve ensuring acceptable levels of residual moisture, microbial contaminants, and potential residual toxins, consistent with international food enzyme specifications. In many global contexts, enzyme preparations intended for food use are expected to comply with identity and purity criteria established by organizations such as the Joint FAO/WHO Expert Committee on Food Additives (JECFA) and codified food safety frameworks, although specific entries for this particular enzyme preparation may not be present in public JECFA listings.
Why It Is Used In Food
Lactase from Saccharomyces fragilis is used in food processing because of its specific catalytic ability to hydrolyze lactose into simpler sugars such as glucose and galactose. This biochemical reaction is particularly valuable in the dairy industry, where lactose content can be a functional concern for product quality and consumer tolerance. By adding lactase during processing, dairy manufacturers can reduce the level of lactose in milk, whey, and other dairy-derived products, helping improve product quality attributes such as sweetness, solubility, and digestibility in certain consumer populations. The decision to include lactase in processing is driven by its technical function rather than any direct nutritional contribution, as the enzyme facilitates the transformation of an existing carbohydrate component of the food matrix. In practical terms, the use of lactase allows producers to modify the carbohydrate profile of foods in ways that align with product positioning and consumer needs. For example, reducing lactose can help mitigate issues like lactose crystallization in sweetened condensed milk or enhance the processing of whey-based ingredients. In some markets, lactose-reduced or lactose-modified products are developed to cater to individuals who experience discomfort from consuming intact lactose, although lactase use is primarily a processing tool and not intended as a therapeutic agent. The metabolic breakdown of lactose by the enzyme increases the relative sweetness of the resulting product because glucose and galactose are perceived as sweeter than lactose, which can influence formulation decisions. The use of enzyme preparations in food processing, including lactase, is typically governed by established food safety and quality frameworks that require adherence to good manufacturing practices and, where relevant, compliance with identity and purity criteria. Enzyme preparations are not consumed as intact ingredients but rather function during processing, after which residual enzyme may be removed or remain at levels considered technologically justified. The rationale for using lactase in food applications is centered on its efficient catalysis of lactose hydrolysis and its compatibility with a range of dairy processing environments.
Adi Example Calculation
ADI Example Calculation (Illustrative): Because a specific Acceptable Daily Intake (ADI) value for lactase from Saccharomyces fragilis is not established in available regulatory sources, a hypothetical illustrative calculation cannot be performed with a definitive numeric ADI for this ingredient. ADI values are typically set by regulatory bodies when sufficient toxicological data exist to define a safe exposure level, expressed in milligrams per kilogram of body weight per day. In the absence of a specific numeric ADI, regulatory guidance for enzyme preparations emphasizes adherence to good manufacturing practices and purity criteria rather than applying a formal ADI to estimate daily intake limits. Illustrative ADI calculations normally begin with an established numeric ADI. For instance, if an enzyme had an ADI of X mg per kg body weight per day, and the illustrative person weighs 70 kg, the calculation would multiply the ADI by body weight (X mg/kg day times 70 kg) to yield an acceptable daily exposure estimate. However, without a verified ADI value for this specific enzyme preparation in authoritative regulatory resources, any numeric example would be speculative and not grounded in documented regulatory determinations. As a result, no ADI illustration is provided here.
Safety And Health Research
Safety and health research on lactase from Saccharomyces fragilis and related microbial lactase enzyme preparations primarily focuses on the general safety profile of enzyme catalysts used in food processing rather than specific clinical outcomes. Enzyme preparations intended for food processing are evaluated for their potential to introduce harmful substances, such as toxins or contaminants, rather than direct physiological effects, because enzymes are added at technologically necessary levels and do not remain as active catalysts in the final consumer product at levels that raise safety concerns. Regulatory and scientific frameworks for enzyme preparation safety emphasize the selection of nonpathogenic and non-toxigenic production strains and adherence to good manufacturing practices to ensure product quality and minimize unintended contaminants. The Food and Agriculture Organization (FAO) and the World Health Organization (WHO), through bodies like the Joint FAO/WHO Expert Committee on Food Additives (JECFA), and other international authorities provide guidance on the evaluation of enzyme preparations. General considerations for enzyme safety assessments include analysis of the source organism, verification that toxicologically significant mycotoxins are not produced, characterizing the manufacturing process to exclude residual harmful substances, and defining purity criteria that ensure the absence of unacceptable levels of heavy metals or microbial contaminants. These evaluations focus on establishing that the enzyme preparation will not compromise the safety of the processed food when used under conditions consistent with good manufacturing practice. Published databases and guidance documents on enzyme safety emphasize that production strains used for food enzyme generation must be stable and well-characterized, and culture conditions should prevent the introduction of undesirable microorganisms or toxic byproducts. Evaluations include determining the absence of Salmonella, low total coliform counts, and absence of antibiotic activity, among other microbiological criteria. Such safety assessments are standard components of guidelines for the use of food enzymes derived from microbial sources. It is important to distinguish that these safety considerations are technical and regulatory in nature rather than direct human health studies, as the enzyme’s role is to facilitate a specific processing function and residual activity in finished products is typically negligible. Overall, enzyme preparations including lactase from Saccharomyces fragilis are regarded in food science contexts as safe when manufactured and applied according to good practices and established specifications. Specific toxicological or clinical literature tied directly to this enzyme preparation’s use in food processing is limited in public regulatory resources, and no definitive adverse physiological effects are reported when the enzyme is used in compliance with manufacturing and food safety standards.
Regulatory Status Worldwide
Regulatory status worldwide of lactase from Saccharomyces fragilis is characterized by its listing in official ingredient inventories and its alignment with general safety and manufacturing frameworks for food enzymes, though specific codified approvals for defined food uses are not easily identifiable in available public regulatory resources. In the United States, this enzyme preparation appears in the Food and Drug Administration’s Substances Added to Food inventory, which catalogs substances that have been added to food and beverage products or used in food processing. The presence of lactase in this inventory reflects recognition of its existence as a food ingredient or processing aid record without confirming a formal food additive regulation under specific Code of Federal Regulations sections. The FDA inventory itself includes a range of substances that may be directly added to foods or evaluated by external entities such as the Flavor and Extract Manufacturers Association (FEMA) for Generally Recognized As Safe (GRAS) status. However, the inventory entry does not in isolation serve as evidence of a prescriptive regulatory authorization for use levels or applications under the CFR. Internationally, enzyme preparations intended for use in food processing are generally subject to oversight frameworks that emphasize identity, purity, and compliance with good manufacturing practices. Organizations such as the Joint FAO/WHO Expert Committee on Food Additives (JECFA) provide specifications for food enzymes that guide global understanding of enzyme safety and quality, although specific entries for lactase from Saccharomyces fragilis may not be publicly accessible in the searchable JECFA database. JECFA specifications, when available for an enzyme, typically detail identity criteria, purity parameters, and the scope of safety evaluations conducted. In broader global contexts, enzyme preparations produced according to recognized specifications and free from harmful contaminants can be accepted for food processing use through national regulatory mechanisms that incorporate international standards. Because direct numerical regulatory authorizations such as specific CFR sections, E-numbers, or codified international additive lists could not be confidently identified in available regulatory databases for this particular enzyme preparation, regulatory fields related to defined approvals are set to null with explanatory notes. Nonetheless, lactase enzyme preparations are widely used in food processing where acknowledged as safe under good manufacturing practices, and listings in inventories like the FDA Substances Added to Food reflect an official recognition as a documented food substance.
Taste And Functional Properties
Lactase from Saccharomyces fragilis itself does not contribute a distinct taste to foods; its role is functional rather than sensory. When active in a food processing context, the enzyme catalyzes the breakdown of lactose, a sugar that has relatively low sweetness compared to its monosaccharide products. As lactose is hydrolyzed into glucose and galactose, the perceived sweetness of the food matrix can increase because these monosaccharides have higher sweetening power than lactose. This change in sweetness is a secondary effect of the enzyme’s action rather than a direct sensory characteristic of the enzyme preparation itself. In commercial applications, this functional outcome can influence formulation and flavor balancing decisions. From a functional perspective, lactase operates under biochemical conditions that support its catalytic activity, including specific pH and temperature ranges appropriate for the food system. Microbial lactase preparations are typically selected for stability under processing conditions such as moderate temperatures and near-neutral pH ranges encountered in dairy processing. However, the activity of any enzyme can diminish outside its optimal conditions, and manufacturers often evaluate processing parameters to ensure effective lactose hydrolysis without compromising product quality. Unlike ingredients added for flavor, color, or texture, enzyme preparations are valued for their ability to modify specific molecular structures within foods, with minimal direct impact on the organoleptic properties beyond the changes induced by their catalytic action. The formulation of enzyme preparations may involve carriers or stabilizers that support the physical stability of the enzyme during storage and handling. Such carriers are chosen to be inert and not interfere with food quality or safety. Enzyme preparations are often formulated to maintain activity across typical storage conditions, but like all proteins, they can be susceptible to denaturation by extreme heat, pH shifts, or proteolytic degradation. As a result, enzyme suppliers provide technical specifications regarding optimal usage conditions to help processors integrate the enzyme into production workflows effectively. Ultimately, the functional attributes of lactase are defined by its enzymatic activity and how that activity influences the properties of the food system being processed rather than by intrinsic taste or texture contributions.
Acceptable Daily Intake Explained
Acceptable Daily Intake (ADI) is a concept used in regulatory science to describe an estimate of the amount of a food additive or chemical substance that can be ingested daily over a lifetime without posing appreciable health risk, based on available toxicological data. ADI is typically expressed in milligrams of substance per kilogram of body weight per day and is derived from experimental studies that identify a no observed adverse effect level (NOAEL) and apply safety factors to account for uncertainties in extrapolating from animal models to humans. For enzyme preparations such as lactase from Saccharomyces fragilis, specific ADI values are not always established or published because enzymes used in food processing often function during intermediate stages and are either removed or present at minimal residual levels in finished products. Enzymes like lactase are typically evaluated in terms of purity, absence of harmful contaminants, and technological necessity rather than numeric ADIs, especially when they are used as processing aids under good manufacturing practices. When an ADI is assigned to an additive by regulatory bodies such as the Joint FAO/WHO Expert Committee on Food Additives (JECFA) or the European Food Safety Authority (EFSA), it provides a quantitative benchmark for safety evaluation. However, in the absence of a specific regulatory ADI for a particular enzyme preparation, general safety frameworks emphasize adherence to manufacturing and quality standards to minimize exposure and ensure that residual enzyme levels in food products do not raise safety concerns. Therefore, for lactase from Saccharomyces fragilis, an explicit ADI is not established in the available regulatory databases, and this reflects a context where safety considerations focus on purity and production practices rather than lifetime intake thresholds.
Comparison With Similar Additives
Comparison with Similar Additives: Lactase from Saccharomyces fragilis functions within the broader category of food enzymes used to modify specific components of food matrices. Comparable enzyme preparations include other microbial lactases derived from organisms such as Kluyveromyces lactis, which are used similarly to catalyze lactose hydrolysis in dairy systems. Both enzyme types serve the same core function of breaking lactose into simpler sugars, though they may differ in terms of optimal activity profiles depending on production strain and processing conditions. Another related food enzyme category is beta-D-galactosidase preparations used to generate galacto-oligosaccharides, which serve technological roles in creating prebiotic ingredients. While similar in catalytic activity, the focus for galacto-oligosaccharide-producing preparations emphasizes generating specific oligosaccharide profiles rather than simply reducing lactose levels. On the other hand, carbohydrate-modifying enzymes such as amylases and cellulases act on distinct substrates like starch or cellulose to produce sugars, dextrins, or to modify texture in baked goods or other food systems. These enzymes share the common feature of being microbial-derived catalysts with targeted functions in food processing. Compared with direct chemical additives like emulsifiers or stabilizers, enzyme preparations such as lactases are unique in that they do not remain chemically unchanged in the finished product but instead facilitate a biotransformation. This difference influences how enzyme preparations are regulated and evaluated, focusing on purity and operational conditions rather than fixed functional contributions such as viscosity or emulsification. Overall, lactase from Saccharomyces fragilis is part of a suite of food enzyme tools that provide targeted biochemical modifications to enhance processing outcomes.
Common Food Applications Narrative
Lactase from Saccharomyces fragilis finds its place in a range of food processing scenarios where modification of lactose content is technologically desirable. In dairy processing, the enzymatic hydrolysis of lactose facilitates the production of lactose-reduced and lactose-modified milk products, which can improve functional attributes like sweetness and digestibility. Lactase preparations are often used in the manufacture of milk products destined for markets or consumer segments where lower lactose levels are preferred for quality or tolerance reasons. Beyond fluid milk, lactose modulation can be relevant in products where crystallization, sweetness balance, or solubility is important, such as in whey-based ingredients and concentrated dairy products. In addition to its role in conventional dairy processing, lactase serves as a tool for reformulating dairy-derived ingredients used in a broader array of food categories. For example, whey protein concentrates that undergo lactose hydrolysis can exhibit enhanced solubility and reduced sweetness, which may be advantageous in beverage formulations and nutritional products. Similarly, lactose-modified dairy ingredients are often employed in bakery and confectionery systems where lactose crystallization could impact texture. Lactase also supports the development of specialty dairy products that target specific consumer preferences, such as foods with altered carbohydrate profiles. Because lactase functions enzymatically during processing rather than as a direct addition to impart flavor or texture, its applications are linked to the technical objectives of modifying lactose content. The enzyme is typically introduced at a defined stage in the processing workflow and allowed to act under conditions optimized for catalytic activity, after which the product moves on to further processing steps. The use of lactase from Saccharomyces fragilis reflects the broader category of microbial enzyme preparations employed across food systems to achieve molecular-level changes that support product quality, formulation flexibility, and alignment with technological goals.
Safety & Regulations
FDA
- Notes: Inclusion in FDA Substances Added to Food inventory does not confirm a specific food additive approval; formal regulation not identified.
EFSA
- Notes: No specific EFSA additive evaluation with numeric ADI identified.
JECFA
- Notes: No specific JECFA numeric ADI or year entry identified in searchable records.
Comments
Please login to leave a comment.
No comments yet. Be the first to share!